Practice Variability in Screening and Treating Pediatric Critical Illness Delirium: Survey

Abstract

The best practice in pediatric delirium (PD) screening and treatment is still unknown. Current recommendations come from small studies and adult data. In this article, we surveyed the Pediatric Critical Care Medicine fellowship directors on PD screening and treatment practices in their centers. We reported high variability in the screening and treatment practices for PD in large academic medical centers in the United States. The Cornell Assessment of Pediatric Delirium tool is the most commonly used tool for screening, and quetiapine is the most commonly used pharmacologic agent. A national guideline on PD screening, prevention, and treatment is needed to standardize practice and provide guidance.

Keywords

delirium - critical care - pediatric - intensive care units - children - screening

Publikationsverlauf

Eingereicht: 02. Juli 2020

Angenommen: 06. August 2020

Artikel online veröffentlicht:
07. September 2020

• References

• 1 Silver G, Traube C, Gerber LM. et al. Pediatric delirium and associated risk factors: a single-center prospective observational study. Pediatr Crit Care Med 2015; 16 (04) 303-309
• 2 Joyce C, Witcher R, Herrup E. et al. Evaluation of the safety of quetiapine in treating delirium in critically ill children: a retrospective review. J Child Adolesc Psychopharmacol 2015; 25 (09) 666-670
• 3 Smith HAB, Gangopadhyay M, Goben CM. et al. Delirium and benzodiazepines associated with prolonged ICU stay in critically ill infants and young children. Crit Care Med 2017; 45 (09) 1427-1435
• 4 Harris J, Ramelet AS, van Dijk M. et al. Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals. Intensive Care Med 2016; 42 (06) 972-986
• 5 Traube C, Silver G, Reeder RW. et al. Delirium in critically ill children: an international point prevalence study. Crit Care Med 2017; 45 (04) 584-590
• 6 Traube C, Silver G, Gerber LM. et al. Delirium and mortality in critically Ill children: epidemiology and outcomes of pediatric delirium. Crit Care Med 2017; 45 (05) 891-898
• 7 Patel AK, Bell MJ, Traube C. Delirium in pediatric critical care. Pediatr Clin North Am 2017; 64 (05) 1117-1132
• 8 Silver GH, Kearney JA, Bora S. PATHWAYS FOR CLINICAL CARE WORKGROUP, et al. A clinical pathway to standardize care of children with delirium in pediatric inpatient settings. Hosp Pediatr 2019; 9 (11) 909-916
• 9 Traube C, Mauer EA, Gerber LM. et al. Cost associated with pediatric delirium in the ICU. Crit Care Med 2016; 44 (12) e1175-e1179
• 10 Girard TD, Jackson JC, Pandharipande PP. et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010; 38 (07) 1513-1520
• 11 Meyburg J, Ries M, Zielonka M. et al. Cognitive and behavioral consequences of pediatric delirium: a pilot study. Pediatr Crit Care Med 2018; 19 (10) e531-e537
• 12 Malas N, Brahmbhatt K, McDermott C, Smith A, Ortiz-Aguayo R, Turkel S. Pediatric delirium: evaluation, management, and special considerations. Curr Psychiatry Rep 2017; 19 (09) 65
• 13 Kudchadkar SR, Yaster M, Punjabi NM. Sedation, sleep promotion, and delirium screening practices in the care of mechanically ventilated children: a wake-up call for the pediatric critical care community*. Crit Care Med 2014; 42 (07) 1592-1600
• 14 Kishk OA, Simone S, Lardieri AB, Graciano AL, Tumulty J, Edwards S. Antipsychotic treatment of delirium in critically ill children: a retrospective matched cohort study. J Pediatr Pharmacol Ther 2019; 24 (03) 204-213
• 15 Van Cauteren YJ, Van Tuijl SG, Schieveld JN. The need for an international standardized guideline regarding pediatric delirium--reply to the letter by giusti et al. Minerva Anestesiol 2015; 81 (04) 462-463
• 16 Winsnes K, Sochacki P, Eriksson C. et al. Delirium in the pediatric hematology, oncology, and bone marrow transplant population. Pediatr Blood Cancer 2019; 66 (06) e27640
• 17 Turkel SB. Pediatric delirium: recognition, management, and outcome. Curr Psychiatry Rep 2017; 19 (12) 101
• 18 Sikich N, Lerman J. Development and psychometric evaluation of the pediatric anesthesia emergence delirium scale. Anesthesiology 2004; 100 (05) 1138-1145
• 19 Smith HA, Boyd J, Fuchs DC. et al. Diagnosing delirium in critically ill children: validity and reliability of the pediatric confusion assessment method for the intensive care unit. Crit Care Med 2011; 39 (01) 150-157
• 20 Smith HA, Gangopadhyay M, Goben CM. et al. The preschool confusion assessment method for the ICU: valid and reliable delirium monitoring for critically ill infants and children. Crit Care Med 2016; 44 (03) 592-600
• 21 Silver G, Traube C, Kearney J. et al. Detecting pediatric delirium: development of a rapid observational assessment tool. Intensive Care Med 2012; 38 (06) 1025-1031
• 22 Traube C, Silver G, Kearney J. et al. Cornell assessment of pediatric delirium: a valid, rapid, observational tool for screening delirium in the PICU*. Crit Care Med 2014; 42 (03) 656-663
• 23 Campbell CT, Grey E, Munoz-Pareja J, Manasco KB. An evaluation of risperidone dosing for pediatric delirium in children less than or equal to 2 years of age. Ann Pharmacother 2020; 54 (05) 464-469
• 24 Barr J, Fraser GL, Puntillo K. American College of Critical Care Medicine, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013; 41 (01) 263-306
• 25 Turkel SB, Jacobson J, Munzig E, Tavaré CJ. Atypical antipsychotic medications to control symptoms of delirium in children and adolescents. J Child Adolesc Psychopharmacol 2012; 22 (02) 126-130
• 26 Van Tuijl SG, Van Cauteren YJ, Pikhard T, Engel M, Schieveld JN. Management of pediatric delirium in critical illness: a practical update. Minerva Anestesiol 2015; 81 (03) 333-341
• 27 Daoud A, Duff JP, Joffe AR. Alberta Sepsis Network. Diagnostic accuracy of delirium diagnosis in pediatric intensive care: a systematic review. Crit Care 2014; 18 (05) 489
• 28 Sassano-Higgins S, Freudenberg N, Jacobson J, Turkel S. Olanzapine reduces delirium symptoms in the critically ill pediatric patient. J Pediatr Intensive Care 2013; 2 (02) 49-54
• 29 Devlin JW, Roberts RJ, Fong JJ. et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010; 38 (02) 419-427
• 30 Slooff VD, Spaans E, van Puijenbroek E. et al. Adverse events of haloperidol for the treatment of delirium in critically ill children. Intensive Care Med 2014; 40 (10) 1602-1603
• 31 Bettencourt A, Mullen JE. Delirium in Children: Identification, Prevention, and Management. Crit Care Nurse 2017; 37 (03) e9-e18
• 32 Turkel SB, Hanft A. The pharmacologic management of delirium in children and adolescents. Paediatr Drugs 2014; 16 (04) 267-274
• 33 Capino AC, Thomas AN, Baylor S, Hughes KM, Miller JL, Johnson PN. Antipsychotic Use in the Prevention and Treatment of Intensive Care Unit Delirium in Pediatric Patients. J Pediatr Pharmacol Ther 2020; 25 (02) 81-95
• 34 Traube C, Witcher R, Mendez-Rico E, Silver G. Quetiapine as treatment for delirium in critically ill children: a case series. J Pediatr Intensive Care 2013; 2 (03) 121-126
• 35 Rasimas JJ, Liebelt EL. Adverse effects and toxicity of the atypical antipsychotics: what is important for the pediatric emergency medicine practitioner. Clin Pediatr Emerg Med 2012; 13 (04) 300-310